- Home
- CATX vs BMN Comparison
CATX vs BMN Comparison
Compare CATX & BMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CATX
- BMN
- Stock Information
- Founded
- CATX 1983
- BMN 2020
- Country
- CATX United States
- BMN United States
- Employees
- CATX N/A
- BMN 19800
- Industry
- CATX Medical/Dental Instruments
- BMN Trusts Except Educational Religious and Charitable
- Sector
- CATX Health Care
- BMN Finance
- Exchange
- CATX Nasdaq
- BMN Nasdaq
- Market Cap
- CATX 133.3M
- BMN 152.5M
- IPO Year
- CATX N/A
- BMN N/A
- Fundamental
- Price
- CATX $1.94
- BMN $23.79
- Analyst Decision
- CATX Strong Buy
- BMN
- Analyst Count
- CATX 10
- BMN 0
- Target Price
- CATX $13.89
- BMN N/A
- AVG Volume (30 Days)
- CATX 950.5K
- BMN 29.9K
- Earning Date
- CATX 05-12-2025
- BMN 01-01-0001
- Dividend Yield
- CATX N/A
- BMN 4.66%
- EPS Growth
- CATX N/A
- BMN N/A
- EPS
- CATX N/A
- BMN N/A
- Revenue
- CATX $1,454,000.00
- BMN N/A
- Revenue This Year
- CATX N/A
- BMN N/A
- Revenue Next Year
- CATX $1.15
- BMN N/A
- P/E Ratio
- CATX N/A
- BMN N/A
- Revenue Growth
- CATX 1.40
- BMN N/A
- 52 Week Low
- CATX $1.60
- BMN $21.51
- 52 Week High
- CATX $19.10
- BMN $25.59
- Technical
- Relative Strength Index (RSI)
- CATX 41.33
- BMN 26.19
- Support Level
- CATX $1.60
- BMN $23.04
- Resistance Level
- CATX $2.11
- BMN $24.00
- Average True Range (ATR)
- CATX 0.21
- BMN 0.58
- MACD
- CATX 0.03
- BMN -0.09
- Stochastic Oscillator
- CATX 55.74
- BMN 32.05
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
About BMN BlackRock 2037 Municipal Target Term Trust of Beneficial Interest
BlackRock 2037 Mun Tgt is a non-diversified, closed-end management investment company. The Trust's investment objective is to provide current income that is exempt from regular federal income tax. The Trust invests in investment grade quality securities or securities that are unrated but judged to be of comparable quality by the investment adviser.